litlas
Log inCreate account

Paul Russo

Active 1975–2025

192
Papers
43,271
Citations
103
h-index
184
i10-index

Citations

Citations per year for Paul Russo1976: 1 citations1977: 1 citations1982: 1 citations1985: 1 citations1986: 1 citations1987: 1 citations1988: 4 citations1989: 4 citations1990: 2 citations1991: 5 citations1992: 8 citations1993: 8 citations1994: 13 citations1995: 14 citations1996: 8 citations1997: 21 citations1998: 17 citations1999: 19 citations2000: 31 citations2001: 45 citations2002: 72 citations2003: 84 citations2004: 129 citations2005: 145 citations2006: 193 citations2007: 226 citations2008: 224 citations2009: 244 citations2010: 305 citations2011: 269 citations2012: 310 citations2013: 232 citations2014: 206 citations2015: 183 citations2016: 223 citations2017: 233 citations2018: 269 citations2019: 918 citations2020: 1,182 citations2021: 1,199 citations2022: 1,001 citations2023: 741 citations2024: 1,140 citations2025: 472 citations2026: 14 citations1978–1981: no citations, so these years are not shown1983–1984: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,654 citing papers, 27.7% of this breakdownChina: 1,985 citing papers, 15% of this breakdownItaly: 857 citing papers, 6.5% of this breakdownGermany: 668 citing papers, 5% of this breakdownUnited Kingdom: 655 citing papers, 4.9% of this breakdownFrance: 539 citing papers, 4.1% of this breakdownCanada: 525 citing papers, 4% of this breakdownNetherlands: 352 citing papers, 2.7% of this breakdownSpain: 341 citing papers, 2.6% of this breakdownJapan: 340 citing papers, 2.6% of this breakdownAustralia: 272 citing papers, 2% of this breakdownSwitzerland: 237 citing papers, 1.8% of this breakdown
0%27.7%Other 21.1%

Institutions

Fields

  • Medicine72.3%
  • Biochemistry, Genetics and Molecular Biology17.8%
  • Immunology and Microbiology3.7%
  • Chemistry1.3%
  • Engineering1.3%
  • Computer Science0.9%
  • Other2.7%

Topics

  • Renal cell carcinoma treatment12.5%
  • Cancer Immunotherapy and Biomarkers7%
  • Bladder and Urothelial Cancer Treatments5%
  • Renal and related cancers4.2%
  • Ferroptosis and cancer prognosis4.2%
  • Cancer Genomics and Diagnostics4.2%
  • Other62.9%

Coauthors

All papers

Open in search
  1. Tumor mutational load predicts survival after immunotherapy across multiple cancer types

    Authors: Robert Samstein, Chung‐Han Lee, Alexander N. Shoushtari, Matthew D. Hellmann, Ronglai Shen, Yelena Y. Janjigian, David Barron, Ahmet Zehir, Emmet Jordan, Antonio Omuro, Thomas Kaley, Sviatoslav M. Kendall, Robert J. Motzer, A. Ari Hakimi, Martin H. Voss, Paul Russo, Jonathan E. Rosenberg, Gopa Iyer, Bernard H. Bochner, Dean F. Bajorin, Hikmat Al‐Ahmadie, Jamie E. Chaft, Charles M. Rudin, Gregory J. Riely, Shrujal S. Baxi, Alan L. Ho, Richard J. Wong, David G. Pfister, Jedd D. Wolchok, Christopher A. Barker, Philip H. Gutin, Cameron Brennan, Viviane Tabar, Ingo K. Mellinghoff, Lisa M. DeAngelis, Charlotte E. Ariyan, Nancy Y. Lee, William D. Tap, Mrinal M. Gounder, Sandra P. D’Angelo, Leonard B. Saltz, Zsofia K. Stadler, Howard I. Scher, José Baselga, Pedram Razavi, Christopher A. Klebanoff, Rona Yaeger, Neil H. Segal, Geoffrey Y. Ku, Ronald P. DeMatteo, Marc Ladanyi, Naiyer A. Rizvi, Michael F. Berger, Nadeem Riaz, David B. Solit, Timothy A. Chan, Luc G.T. Morris - Nature Genetics 2019 cited by 4,358

  2. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

    Authors: Bastien Nguyen, Christopher J. Fong, Anisha Luthra, Shaleigh Smith, Renzo G. DiNatale, Subhiksha Nandakumar, Henry Walch, Walid K. Chatila, Ramyasree Madupuri, Ritika Kundra, Craig M. Bielski, Brooke Mastrogiacomo, Mark T.A. Donoghue, Adrienne Boire, Sarat Chandarlapaty, Karuna Ganesh, James J. Harding, Christine A. Iacobuzio–Donahue, Pedram Razavi, Ed Reznik, Charles M. Rudin, Dmitriy Zamarin, Wassim Abida, Ghassan K. Abou‐Alfa, Carol Aghajanian, Andrea Cercek, Ping Chi, Darren R. Feldman, Alan L. Ho, Gopa Iyer, Yelena Y. Janjigian, Michael J. Morris, Robert J. Motzer, Eileen M. O’Reilly, Michael A. Postow, Nitya Raj, Gregory J. Riely, Mark E. Robson, Jonathan E. Rosenberg, Anton Safonov, Alexander N. Shoushtari, William D. Tap, Min Yuen Teo, Anna M. Varghese, Martin H. Voss, Rona Yaeger, Marjorie G. Zauderer, Nadeem R. Abu‐Rustum, Julio García‐Aguilar, Bernard H. Bochner, A. Ari Hakimi, William R. Jarnagin, David R. Jones, Daniela Molena, Luc G.T. Morris, Eric Rios‐Doria, Paul Russo, Samuel Singer, Vivian E. Strong, Debyani Chakravarty, Lora H. Ellenson, Anuradha Gopalan, Jorge S. Reis‐Filho, Britta Weigelt, Marc Ladanyi, Mithat Gönen, Sohrab P. Shah, Joan Massagué, Jianjiong Gao, Ahmet Zehir, Michael F. Berger, David B. Solit, Samuel F. Bakhoum, Francisco Sánchez-Vega, Nikolaus Schultz - Cell 2022 cited by 663

  3. Epidemiology of Renal Cell Carcinoma

    Authors: Umberto Capitanio, Karim Bensalah, Axel Bex, Stephen A. Boorjian, Freddie Bray, Jonathan Coleman, John L. Gore, Maxine Sun, Christopher G. Wood, Paul Russo - European Urology 2018 cited by 1,655

  4. Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy

    Authors: Chirag Krishna, Renzo G. DiNatale, Fengshen Kuo, Raghvendra M. Srivastava, Lynda Vuong, Diego Chowell, Sounak Gupta, Chad Vanderbilt, Tanaya A. Purohit, Ming Liu, Emily R. Kansler, Briana G. Nixon, Ying‐Bei Chen, Vladimir Makarov, Kyle A. Blum, Kyrollis Attalla, Stanley Weng, Michael Salmans, Mahdi Golkaram, Li Liu, Shile Zhang, Raakhee Vijayaraghavan, Traci Pawlowski, Victor E. Reuter, Maria I. Carlo, Martin H. Voss, Jonathan Coleman, Paul Russo, Robert J. Motzer, Ming O. Li, Christina S. Leslie, Timothy A. Chan, A. Ari Hakimi - Cancer Cell 2021 cited by 439

  5. An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma

    Authors: A. Ari Hakimi, Ed Reznik, Chung‐Han Lee, Chad J. Creighton, A. Rose Brannon, Augustin Luna, Bülent Arman Aksoy, Eric Minwei Liu, Ronglai Shen, William Lee, Yang Chen, Steve Stirdivant, Paul Russo, Ying‐Bei Chen, Satish K. Tickoo, Victor E. Reuter, Emily H. Cheng, Chris Sander, James J. Hsieh - Cancer Cell 2016 cited by 854

  6. Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures

    Authors: Yasin Şenbabaoğlu, Ron S. Gejman, Andrew Winer, Ming Liu, Eliezer M. Van Allen, Guillermo de Velasco, Diana Miao, Irina Ostrovnaya, Esther Drill, Augustin Luna, Nils Weinhold, William Lee, Brandon J. Manley, Danny N. Khalil, Samuel D. Kaffenberger, Ying‐Bei Chen, Ludmila Danilova, Martin H. Voss, Jonathan Coleman, Paul Russo, Victor E. Reuter, Timothy A. Chan, Emily H. Cheng, David A. Scheinberg, Ming O. Li, Toni K. Choueiri, James J. Hsieh, Chris Sander, A. Ari Hakimi - Genome biology 2016 cited by 1,042

  7. Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial

    Authors: Robert J. Motzer, Paul Russo, Viktor Grünwald, Yoshihiko Tomita, Bogdan Żurawski, Omi Parikh, Sebastiano Buti, Philippe Barthélémy, Jeffrey C. Goh, Dingwei Ye, Alejo Lingua, Jean‐Baptiste Lattouf, Laurence Albigès, Saby George, Brian Shuch, Jeffrey A. Sosman, Michael Staehler, Sergio Vázquez Estévez, Burçin Şimşek, Julia Spiridigliozzi, Aleksander Chudnovsky, Axel Bex - The Lancet 2023 cited by 172

  8. Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer

    Authors: Johannes Schödel, Steffen Grampp, Eamonn R. Maher, Holger Moch, Peter J. Ratcliffe, Paul Russo, David R. Mole - European Urology 2015 cited by 423

  9. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

    Authors: Bastien Nguyen, Christopher J. Fong, Anisha Luthra, Shaleigh Smith, Renzo G. DiNatale, Subhiksha Nandakumar, Henry Walch, Walid K. Chatila, Ramyasree Madupuri, Ritika Kundra, Craig M. Bielski, Brooke Mastrogiacomo, Adrienne Boire, Sarat Chandarlapaty, Karuna Ganesh, James J. Harding, Christine A. lacobuzio-Donahue, Pedram Razavi, Ed Reznik, Charles M. Rudin, Dmitriy Zamarin, Wassim Abida, Ghassan K. Abou‐Alfa, Carol Aghajanian, Andrea Cercek, Ping Chi, Darren R. Feldman, Alan L. Ho, Gopa Iyer, Yelena Y. Janjigian, Michael J. Morris, Robert J. Motzer, Eileen M. O’Reilly, Michael A. Postow, Nitya Raj, Gregory J. Riely, Mark E. Robson, Jonathan E. Rosenberg, Anton Safonov, Alexander N. Shoushtari, William D. Tap, Min Yuen Teo, Anna M. Varghese, Martin H. Voss, Rona Yaeger, Marjorie G. Zauderer, Nadeem R. Abu‐Rustum, Julio García‐Aguilar, Bernard H. Bochner, A. Ari Hakimi, William R. Jarnagin, David R. Jones, Daniela Molena, Luc G.T. Morris, Eric Rios‐Doria, Paul Russo, Samuel Singer, Vivian E. Strong, Debyani Chakravarty, Lora H. Ellenson, Anuradha Gopalan, Jorge S. Reis‐Filho, Britta Weigelt, Marc Ladanyi, Mithat Gönen, Sohrab P. Shah, Joan Massagué, Jianjiong Gao, Ahmet Zehir, Michael F. Berger, David B. Solit, Samuel F. Bakhoum, Francisco Sánchez-Vega, Nikolaus Schultz - 2021 cited by 69

  10. Sarcomatoid renal cell carcinoma: biology, natural history and management

    Authors: Kyle A. Blum, Sounak Gupta, Satish K. Tickoo, Timothy A. Chan, Paul Russo, Robert J. Motzer, José A. Karam, A. Ari Hakimi - Nature Reviews Urology 2020 cited by 204

  11. Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2 : A Report by MSKCC and the KIRC TCGA Research Network

    Authors: A. Ari Hakimi, Irina Ostrovnaya, Boris Reva, Nikolaus Schultz, Ying‐Bei Chen, Mithat Gönen, Han Liu, Shugaku Takeda, Martin H. Voss, Satish K. Tickoo, Victor E. Reuter, Paul Russo, Emily H. Cheng, Chris Sander, Robert J. Motzer, James J. Hsieh - Clinical Cancer Research 2013 cited by 354

  12. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study

    Authors: William C. Huang, Andrew S. Levey, Angel M. Serio, Mark E. Snyder, Andrew J. Vickers, Ganesh V. Raj, Peter T. Scardino, Paul Russo - The Lancet Oncology 2006 cited by 1,608

  13. Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline

    Authors: Antonio Finelli, Nofisat Ismaila, Bill Bro, Jeremy C. Durack, Scott Eggener, Andrew Evans, Inderbir S. Gill, David L. Graham, William C. Huang, Michael A.S. Jewett, Sheron Latcha, William T. Lowrance, Mitchell H. Rosner, Bobby Shayegan, R. Houston Thompson, Robert G. Uzzo, Paul Russo - Journal of Clinical Oncology 2017 cited by 376

  14. Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape

    Authors: Mahdi Golkaram, Fengshen Kuo, Sounak Gupta, Maria I. Carlo, Michael Salmans, Raakhee Vijayaraghavan, Cerise Tang, Vlad Makarov, Phillip M. Rappold, Kyle A. Blum, Chen Zhao, Rami Mehio, Shile Zhang, Jim Godsey, Traci Pawlowski, Renzo G. DiNatale, Luc G.T. Morris, Jeremy C. Durack, Paul Russo, Ritesh R. Kotecha, Jonathan Coleman, Ying‐Bei Chen, Victor E. Reuter, Robert J. Motzer, Martin H. Voss, Li Liu, Ed Reznik, Timothy A. Chan, A. Ari Hakimi - Genome Medicine 2022 cited by 46

  15. Interferon-Alfa as a Comparative Treatment for Clinical Trials of New Therapies Against Advanced Renal Cell Carcinoma

    Authors: Robert J. Motzer, Jennifer Bacik, Barbara A. Murphy, Paul Russo, Madhu Mazumdar - Journal of Clinical Oncology 2002 cited by 1,505

  16. An Epidemiologic and Genomic Investigation Into the Obesity Paradox in Renal Cell Carcinoma

    Authors: A. Ari Hakimi, Helena Furberg, Emily C. Zabor, Anders J. Skanderup, Nikolaus Schultz, Giovanni Ciriello, Nina Mikklineni, Brandon Fiegoli, Philip H. Kim, Martin H. Voss, Hui Shen, Peter W. Laird, Chris Sander, Victor E. Reuter, Robert J. Motzer, James J. Hsieh, Paul Russo - JNCI Journal of the National Cancer Institute 2013 cited by 289

  17. Phase II Study of Neoadjuvant Nivolumab in Patients with Locally Advanced Clear Cell Renal Cell Carcinoma Undergoing Nephrectomy

    Authors: Maria I. Carlo, Kyrollis Attalla, Yousef Mazaheri, Sounak Gupta, Onur Yıldırım, Samuel Murray, Devyn Taylor Coskey, Ritesh R. Kotecha, Chung‐Han Lee, Darren R. Feldman, Paul Russo, Sujata Patil, Robert J. Motzer, Jonathan Coleman, Jeremy C. Durack, Ying‐Bei Chen, Oğuz Akın, A. Ari Hakimi, Martin H. Voss - European Urology 2022 cited by 63

  18. Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome–associated Renal Cancer

    Authors: Ying‐Bei Chen, A. Rose Brannon, Antoun Toubaji, Mária Dudás, Helen Won, Hikmat Al‐Ahmadie, Samson W. Fine, Anuradha Gopalan, Norma Frizzell, Martin H. Voss, Paul Russo, Michael F. Berger, Satish K. Tickoo, Victor E. Reuter - The American Journal of Surgical Pathology 2014 cited by 272

  19. Positron Emission Tomography/Computed Tomography Identification of Clear Cell Renal Cell Carcinoma: Results From the REDECT Trial

    Authors: Chaitanya Divgi, Robert G. Uzzo, Constantine Gatsonis, Roman Bartz, Silke Treutner, Jian Q. Yu, David Chen, Jorge A. Carrasquillo, Steven M. Larson, Paul Bevan, Paul Russo - Journal of Clinical Oncology 2012 cited by 258

  20. Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma

    Authors: Robert J. Motzer, Naomi B. Haas, Frede Donskov, Marine Gross‐Goupil, Sergei Varlamov, Evgeny Kopyltsov, Jae‐Lyun Lee, Bohuslav Melichar, Brian I. Rini, Toni K. Choueiri, Milada Zemanová, Lori Wood, M. Neil Reaume, Arnulf Stenzl, Simon Chowdhury, Ho Yeong Lim, Ray McDermott, Agnieszka Michael, Weichao Bao, Marlene J. Carrasco-Alfonso, Paola Aimone, Maurizio Voi, Christian Doehn, Paul Russo, Cora N. Sternberg, on behalf of the PROTECT investigators - Journal of Clinical Oncology 2017 cited by 387

  21. Guideline for Management of the Clinical T1 Renal Mass

    Authors: Steven C. Campbell, Andrew C. Novick, Arie S. Belldegrun, Michael L. Blute, George K. Chow, Ithaar Derweesh, Martha M. Faraday, Jihad Kaouk, Raymond J. Leveillee, Surena F. Matin, Paul Russo, Robert G. Uzzo - The Journal of Urology 2009 cited by 1,841

  22. A Literature Review of Renal Surgical Anatomy and Surgical Strategies for Partial Nephrectomy

    Authors: Tobias Klatte, Vincenzo Ficarra, Christian Gratzke, Jihad Kaouk, Alexander Kutikov, Veronica Macchi, Alexandre Mottrie, F. Porpiglia, James Porter, Craig Rogers, Paul Russo, R. Houston Thompson, Robert G. Uzzo, Christopher G. Wood, Inderbir S. Gill - European Urology 2015 cited by 286

  23. TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtype

    Authors: A. Ari Hakimi, Satish K. Tickoo, Anders J. Skanderup, Judy Sarungbam, John P. Sfakianos, Yusuke Sato, Teppei Morikawa, Haruki Kume, Masashi Fukayama, Yukio Homma, Ying‐Bei Chen, Alexander Sankin, Roy Mano, Jonathan Coleman, Paul Russo, Seishi Ogawa, Chris Sander, James J. Hsieh, Victor E. Reuter - Modern Pathology 2015 cited by 170

  24. Prognostic Impact of the 2009 UICC/AJCC TNM Staging System for Renal Cell Carcinoma with Venous Extension

    Authors: Juan Ignacio Martínez‐Salamanca, William C. Huang, Isabel Millán, Roberto Bertini, Fernando J. Bianco, Joaquı́n Carballido, Gaetano Ciancio, C. Hernández, Felipe Vilas Herranz, Axel Haferkamp, Markus Hohenfellner, Brian Hu, Theresa M. Koppie, Claudio Martínez‐Ballesteros, Francesco Montorsi, Joan Palou, J. Edson Pontes, Paul Russo, Carlo Terrone, Humberto Villavicencio, Alessandro Volpe, John A. Libertino - European Urology 2010 cited by 275